Corrigendum: Osteoporosis, fractures, and diabetes (International Journal of Endocrinology (2014) 2014 (820615) DOI: 10.1155/2014/820615);Osteoporosis, fractures, and diabetes

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Jackuliak, Peter ^a   Payer, Juraj ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN FIBER; GLITAZONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; OSTEOCALCIN; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE FRAGILITY; BONE MASS; BONE TURNOVER; CLINICAL PRACTICE; COL1A1 GENE; DIABETIC FOOT; DIABETIC NEUROPATHY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; ENZYME ACTIVATION; FALL RISK; FRACTURE; FRACTURE RISK ASSESSMENT TOOL; GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GLUCOSE METABOLISM; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOBLASTOGENESIS; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PROTEIN CROSS LINKING; RISK ASSESSMENT; RISK FACTOR; TRABECULAR BONE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WNT SIGNALING PATHWAY;

EID: 84904208555     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2017/2846080     Document Type: Erratum

References (112)

1. Kurra S., Siris E., Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures. Diabetes/Metabolism Research and Reviews 2011 27 5 430 435 2-s2.0-79960154986 10.1002/dmrr.1197
2. Schwartz A. V., Sellmeyer D. E., Diabetes, fracture, and bone fragility. Current Osteoporosis Reports 2007 5 3 105 111 2-s2.0-35348836163 (Pubitemid 47571960)
3. Janghorbani M., van Dam R. M., Willett W. C., Hu F. B., Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. American Journal of Epidemiology 2007 166 5 495 505 2-s2.0-34548017660 10.1093/aje/kwm106 (Pubitemid 47283633)
4. International Diabetes Federation, IDF Diabetes Atlas 2013 6th Brussels, Belgium International Diabetes Federation
5. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2012 35 supplement 1 S64 S71
6. Hamann C., Kirschner S., Günther K.-P., Hofbauer L. C., Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nature Reviews Endocrinology 2012 8 5 297 305 2-s2.0-84859951837 10.1038/nrendo.2011.233
7. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy, Osteoporosis prevention, diagnosis and therapy. The Journal of the American Medical Association 2001 285 6 785 795
8. Hernlund E., Svedbom A., Ivergård M., Compston J., Cooper C., Stenmark J., McCloskey E. V., Jönsson B., Kanis J. A., A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Osteoporosis in the European Union: medical management, epidemiology and economic burden. Archives of Osteoporosis 2013 8 136 256 10.1007/s11657-013- 0136-1
9. Kanis J. A., Devogelaer J.-P., Gennari C., Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporosis International 1996 6 3 256 261 2-s2.0-0029942211 10.1007/BF01622743 (Pubitemid 26171280)
10. Johnell O., Kanis J. A., Oden A., Johansson H., De Laet C., Delmas P., Eisman J. A., Fujiwara S., Kroger H., Mellstrom D., Meunier P. J., Melton L. J. III, O'Neill T., Pols H., Reeve J., Silman A., Tenenhouse A., Predictive value of BMD for hip and other fractures. Journal of Bone and Mineral Research 2005 20 7 1185 1194 2-s2.0-20844462737 10.1359/JBMR.050304 (Pubitemid 40863806)
11. McClung M. R., Do current management strategies and guidelines adequately address fracture risk? Bone 2006 38 2 S13 S17 2-s2.0-31744440064 10.1016/j.bone.2005.11.012 (Pubitemid 43177167)
12. Johansson H., Kanis J. A., Oden A., Johnell O., McCloskey E., BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporosis International 2009 20 10 1675 1682 2-s2.0-69949131336 10.1007/s00198-009-0845-x
13. Link T. M., Majumdar S., Current diagnostic techniques in the evaluation of bone architecture. Current Osteoporosis Report 2004 2 2 47 52 2-s2.0-23944502354
14. Rubin C. D., Emerging concepts in osteoporosis and bone strength. Current Medical Research and Opinion 2005 21 7 1049 1056 2-s2.0-22744432780 10.1185/030079905X50525 (Pubitemid 41032694)
15. Sawada K., Morishige K.-I., Ohmichi M., Nishio Y., Yamamoto T., Hayakawa J., Mabuchi S., Isobe A., Sasaki H., Sakata M., Tasaka K., Murata Y., Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy. Maturitas 2007 56 4 343 349 2-s2.0-33947159602 10.1016/j.maturitas.2006.08.006 (Pubitemid 46401101)
16. Seeman E., Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 2007 41 3 308 317 2-s2.0-34547561381 10.1016/j.bone.2007.06.010 (Pubitemid 47199158)
17. Vestergaard P., Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporosis International 2007 18 4 427 444 2-s2.0-33847629923 10.1007/s00198-006-0253-4 (Pubitemid 46354916)
18. Nyman J. S., Even J. L., Jo C.-H., Herbert E. G., Murry M. R., Cockrell G. E., Wahl E. C., Bunn R. C., Lumpkin C. K., Fowlkes J. L., Thrailkill K. M., Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone. Bone 2011 48 4 733 740 2-s2.0-79952693871 10.1016/j.bone.2010.12.016
19. Thrailkill K. M., Lumpkin C. K. Jr., Bunn R. C., Kemp S. F., Fowlkes J. L., Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. American Journal of Physiology: Endocrinology and Metabolism 2005 289 5 E735 E745 2-s2.0-27144448386 10.1152/ajpendo.00159.2005 (Pubitemid 41504371)
20. Melton L. J. III, Leibson C. L., Achenbach S. J., Therneau T. M., Khosla S., Fracture risk in type 2 diabetes: update of a population-based study. Journal of Bone and Mineral Research 2008 23 8 1334 1342 2-s2.0-47849121803 10.1359/jbmr.080323 (Pubitemid 352040189)
21. Janghorbani M., Feskanich D., Willett W. C., Hu F., Prospective study of diabetes and risk of hip fracture. Diabetes Care 2006 29 7 1573 1578 2-s2.0-33746419250 10.2337/dc06-0440 (Pubitemid 44127583)
22. Milczarczyk A., Franek E., Osteoporosis and bone fractures in patients with diabetes mellitus. Diabetologia Doświadczalna i Kliniczna 2008 8 2 63 67 2-s2.0-51949096882
23. Brown S. A., Sharples J. L., Osteoporosis: an under-appreciated complication of diabetes. Clinical Diabetes 2004 22 1 10 20
24. Yamagishi S., Nakamura K., Inoue H., Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Medical Hypotheses 2005 65 6 1013 1015 2-s2.0-26444480186 10.1016/j.mehy.2005. 07.017 (Pubitemid 41425882)
25. Strotmeyer E. S., Cauley J. A., Schwartz A. V., Nevitt M. C., Resnick H. E., Bauer D. C., Tylavsky F. A., De Rekeneire N., Harris T. B., Newman A. B., Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Archives of Internal Medicine 2005 165 14 1612 1617 2-s2.0-23744512891 10.1001/archinte.165.14.1612 (Pubitemid 41124155)
26. Gagnon C., Magliano D. J., Ebeling P. R., Dunstan D. W., Zimmet P. Z., Shaw J. E., Daly R. M., Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab). Osteoporosis International 2010 21 12 2067 2074 2-s2.0-78549258091 10.1007/s00198-009-1164-y
27. Gregorio F., Cristallini S., Santeusanio F., Filipponi P., Fumelli P., Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Research and Clinical Practice 1994 23 1 43 54 2-s2.0-0028331598 10.1016/0168-8227(94)90126-0 (Pubitemid 24118514)
28. Viégas M., Costa C., Lopes A., Griz L., Medeiro M. A., Bandeira F., Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. Journal of Diabetes and Its Complications 2011 25 4 216 221 2-s2.0-79959987765 10.1016/j.jdiacomp.2011.02.004
29. de Vittinghoff E Sellmeyer S. A. V., Feingold K. R., de Rekeneire N., Strotmeyer E. S., Shorr R. I., Vinik A. I., Odden M., Park S. W., Faulkner K. A., Harris T. B., Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care 2008 31 5 391 396 2-s2.0-64349090425 10.2337/dc08-er05
30. Monami M., Cresci B., Colombini A., Pala L., Balzi D., Gori F., Chiasserini V., Marchionni N., Rotella C. M., Mannucci E., Bone fractures and hypoglycemic treatment in type 2 diabetic patients. Diabetes Care 2008 31 2 199 203 2-s2.0-38949182323 10.2337/dc07-1736 (Pubitemid 351213319)
31. Sorocéanu M. A., Miao D., Bai X.-Y., Su H., Goltzman D., Karaplis A. C., Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. Journal of Endocrinology 2004 183 1 203 216 2-s2.0-12344255130 10.1677/joe.1.05723 (Pubitemid 40124657)
32. Payer J., Jackuliak P., Killinger Z., Risk of osteoporotic fractures in diabetic patients treated with glitazones treatment. Osteologicky Bulletin 2010 15 2 57 60 2-s2.0-77955615613
33. Nicodemus K. K., Folsom A. R., Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001 24 7 1192 1197 2-s2.0-0035403830 (Pubitemid 33716397)
34. Marchetti P., Lupi R., Bugliani M., Kirkpatrick C. L., Sebastiani G., Grieco F. A., Guerra S. D., D'Aleo V., Piro S., Marselli L., Boggi U., Filipponi F., Tinti L., Salvini L., Wollheim C. B., Purrello F., Dotta F., A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia 2012 55 12 3262 3272 2-s2.0-84868193842 10.1007/s00125-012-2716-9
35. Nuche-Berenguer B., Moreno P., Esbrit P., Dapía S., Caeiro J. R., Cancelas J., Haro-Mora J. J., Villanueva-Peñacarrillo M. L., Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcified Tissue International 2009 84 6 453 461 2-s2.0-67349094596 10.1007/s00223-009-9220-3
36. Valerio G., del Puente A., Esposito-del Puente A., Buono P., Mozzillo E., Franzese A., The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Hormone Research 2002 58 6 266 272 2-s2.0-0036438958 10.1159/000066441 (Pubitemid 35404237)
37. Räkel A., Sheehy O., Rahme E., LeLorier J., Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes and Metabolism 2008 34 3 193 205 2-s2.0-44849133629 10.1016/j.diabet.2007.10.008
38. Hampson G., Evans C., Petitt R. J., Evans W. D., Woodhead S. J., Peters J. R., Ralston S. H., Bone mineral density, collagen type 1 α 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 1998 41 11 1314 1320 2-s2.0-0031794060 10.1007/s001250051071 (Pubitemid 28488759)
39. Bid H., Konwar R., Aggarwal C., Gautam S., Saxena M., Nayak V., Banerjee M., Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian Study. Indian Journal of Medical Sciences 2009 63 5 187 194 2-s2.0-67749142006 10.4103/0019-5359.53164
40. Seeman E., Delmas P. D., Bone quality-the material and structural basis of bone strength and fragility. The New England Journal of Medicine 2006 354 21 2212 2261 2-s2.0-33646889773 10.1056/NEJMra053077
41. Saito M., Marumo K., Bone quality in diabetes. Frontiers in Endocrinology 2013 4, article 72 1 9
42. Brownlee M., Advanced protein glycosylation in diabetes and aging. Annual Review of Medicine 1995 46 223 234 2-s2.0-0028908348 10.1146/annurev.med.46.1. 223
43. Vashishth D., Gibson G. J., Khoury J. I., Schaffler M. B., Kimura J., Fyhrie D. P., Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2001 28 2 195 201 2-s2.0-0035134299 10.1016/S8756-3282(00) 00434-8 (Pubitemid 32140975)
44. Garnero P., Bone markers in osteoporosis. Current Osteoporosis Reports 2009 7 3 84 90 2-s2.0-72449151196 10.1007/s11914-009-0014-3
45. Vasikaran S., Eastell R., Bruyère O., Foldes A. J., Garnero P., Griesmacher A., McClung M., Morris H. A., Silverman S., Trenti T., Wahl D. A., Cooper C., Kanis J. A., Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporosis International 2011 22 2 391 420 2-s2.0-78651493109 10.1007/s00198-010-1501-1
46. Kindblom J. M., Ohlsson C., Ljunggren O., Karlsson M. K., Tivesten Å., Smith U., Mellström D., Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. Journal of Bone and Mineral Research 2009 24 5 785 791 2-s2.0-65949124446 10.1359/jbmr.081234
47. Gerdhem P., Isaksson A., Åkesson K., Obrant K. J., Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporosis International 2005 16 12 1506 1512 2-s2.0-29044434138 10.1007/s00198-005-1877-5 (Pubitemid 41790853)
48. Dobnig H., Piswanger-Sölkner J. C., Roth M., Obermayer-Pietsch B., Tiran A., Strele A., Maier E., Maritschnegg P., Sieberer C., Fahrleitner-Pammer A., Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. Journal of Clinical Endocrinology and Metabolism 2006 91 9 3355 3363 2-s2.0-33748757540 10.1210/jc.2006-0460 (Pubitemid 44402104)
49. Gennari L., Merlotti D., Valenti R., Ceccarelli E., Ruvio M., Pietrini M. G., Capodarca C., Franci M. B., Campagna M. S., Calabrò A., Cataldo D., Stolakis K., Dotta F., Nuti R., Circulating Sclerostin levels and bone turnover in type 1 and type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2012 97 5 1737 1744 2-s2.0-84860714853 10.1210/jc.2011-2958
50. Hauschka P. V., Lian J. B., Cole D. E., Gundberg C. M., Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiological Reviews 1989 69 3 990 1047 2-s2.0-0024370924 (Pubitemid 19184853)
51. Lee N. K., Sowa H., Hinoi E., Ferron M., Ahn J. D., Confavreux C., Dacquin R., Mee P. J., McKee M. D., Jung D. Y., Zhang Z., Kim J. K., Mauvais-Jarvis F., Ducy P., Karsenty G., Endocrine regulation of energy metabolism by the skeleton. Cell 2007 130 3 456 469 2-s2.0-34547690686 10.1016/j.cell.2007.05.047 (Pubitemid 47208519)
52. Ferron M., Hinoi E., Karsenty G., Ducy P., Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proceedings of the National Academy of Sciences of the United States of America 2008 105 13 5266 5270 2-s2.0-42449096306 10.1073/pnas.0711119105 (Pubitemid 351738545)
53. Pittas A. G., Harris S. S., Eliades M., Stark P., Dawson-Hughes B., Association between serum osteocalcin and markers of metabolic phenotype. Journal of Clinical Endocrinology and Metabolism 2009 94 3 827 832 2-s2.0-62349099001 10.1210/jc.2008-1422
54. Svoren B. M., Volkening L. K., Wood J. R., Laffel L. M. B., Significant vitamin D deficiency in youth with type 1 diabetes mellitus. The Journal of Pediatrics 2009 154 1 132 134 2-s2.0-57249096582 10.1016/j.jpeds.2008.07.015
55. Tahrani A. A., Ball A., Shepherd L., Rahim A., Jones A. F., Bates A., The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. International Journal of Clinical Practice 2010 64 3 351 355 2-s2.0-74349096374 10.1111/j.1742-1241.2009.02221.x
56. Bućan K., Ivanišević M., Zemunik T., Boraska V., Škrabić V., Vatavuk Z., Galetović D., Znaor L., Retinopathy and nephropathy in type 1 diabetic patients-association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and Il-1 receptor 1 genes. Collegium Antropologicum 2009 33 2 99 105 2-s2.0-77449149359
57. Diaz V. A., Mainous A. G. III, Carek P. J., Wessell A. M., Everett C. J., The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities. Journal of the American Board of Family Medicine 2009 22 5 521 527 2-s2.0-70349162821 10.3122/jabfm.2009.05. 080231
58. Secchiero P., Corallini F., Pandolfi A., Consoli A., Candido R., Fabris B., Celeghini C., Capitani S., Zauli G., An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. American Journal of Pathology 2006 169 6 2236 2244 2-s2.0-34447624317 10.2353/ajpath.2006.060398 (Pubitemid 351181981)
59. Rasmussen L. M., Tarnow L., Hansen T. K., Parving H.-H., Flyvbjerg A., Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular mordibity in type 1 diabetic patients. European Journal of Endocrinology 2006 154 1 75 81 2-s2.0-32844472729 10.1530/eje.1.02049 (Pubitemid 43250739)
60. Mani A., Radhakrishnan J., Wang H., Mani A., Mani M.-A., Nelson-Williams C., Carew K. S., Mane S., Najmabadi H., Wu D., Lifton R. P., LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007 315 5816 1278 1282 2-s2.0-33847656105 10.1126/science.1136370 (Pubitemid 46364265)
61. Smith U., TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia 2007 50 5 5 7 2-s2.0-33845933521 10.1007/s00125-006-0521-z (Pubitemid 46035845)
62. Owen K. R., McCarthy M. I., Genetics of type 2 diabetes. Current Opinion in Genetics and Development 2007 17 3 239 244 2-s2.0-34249805104 10.1016/j.gde.2007.04.003 (Pubitemid 46850799)
63. Jin T., The WNT signalling pathway and diabetes mellitus. Diabetologia 2008 51 10 1771 1780 2-s2.0-51249114496 10.1007/s00125-008-1084-y
64. Espallargues M., Sampietro-Colom L., Estrada M. D., Solà M., Del Río L., Setoain J., Granados A., Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporosis International 2001 12 10 811 822 2-s2.0-0035178262 10.1007/s001980170031 (Pubitemid 33086268)
65. Wang M. C., Bachrach L. K., van Loan M., Hudes M., Flegal K. M., Crawford P. B., The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 2005 37 4 474 481 2-s2.0-24944533001 10.1016/j.bone.2005.04.038 (Pubitemid 41317320)
66. Barrera G., Bunout D., Gattás V., de la Maza M. P., Leiva L., Hirsch S., A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition 2004 20 9 769 771 2-s2.0-4344607828 10.1016/j.nut.2004.05.014 (Pubitemid 39120035)
67. Felson D. T., Zhang Y., Hannan M. T., Anderson J. J., Effects of weight and body mass index on bone mineral density in men and women: the Framingham Study. Journal of Bone and Mineral Research 1993 8 5 567 573 2-s2.0-0027310187 (Pubitemid 23127916)
68. Compston J., Flahive J., Hosmer D. W., Watts N. B., Siris E. S., Silverman S., Saag K. G., Roux Ch., Rossini M., Pfeilschifter J., Nieves J. W., Netelenbos J. C., March L., LaCroix A. Z., Hooven F. H., Greenspan S. L., Gehlbach S. H., Díez-Pérez A., Cooper C., Chapurlat R. D., Boonen S., Anderson Jr F. A., Adami S., Adachi J. D., Relationship of weight, height and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women (GLOW). Journal of Bone Mineral Research 2014 29 2 487 493
69. Suzuki K., Sugimoto C., Takizawa M., Ishizuka S., Kikuyama M., Togawa H., Taguchi Y., Nosaka K., Seino Y., Ishida H., Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients. Diabetes Research and Clinical Practice 2000 48 3 185 191 2-s2.0-0034095301 10.1016/S0168-8227(00)00119-4 (Pubitemid 30232839)
70. Maurer M. S., Burcham J., Cheng H., Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility. The Journals of Gerontology A: Biological Sciences and Medical Sciences 2005 60 9 1157 1162 2-s2.0-25644444543 (Pubitemid 41384486)
71. Patel S., Hyer S., Tweed K., Kerry S., Allan K., Rodin A., Barron J., Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcified Tissue International 2008 82 2 87 91 2-s2.0-39249084273 10.1007/s00223-007-9082-5
72. Volpato S., Leveille S. G., Blaum C., Fried L. P., Guralnik J. M., Risk factors for falls in older disabled women with diabetes: the Women's Health and Aging Study. The Journals of Gerontology A: Biological Sciences and Medical Sciences 2005 60 12 1539 1545 2-s2.0-31344457729 (Pubitemid 43146459)
73. Kanis J. A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., Burckhardt P., Cooper C., Christiansen C., Cummings S., Eisman J. A., Fujiwara S., Glüer C., Goltzman D., Hans D., Krieg M.-A., La Croix A., McCloskey E., Mellstrom D., Melton L. J. III, Pols H., Reeve J., Sanders K., Schott A.-M., Silman A., Torgerson D., Van Staa T., Watts N. B., Yoshimura N., The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporosis International 2007 18 8 1033 1046 2-s2.0-34347372696 10.1007/s00198-007-0343-y (Pubitemid 47020000)
74. Ensrud K. E., Lui L.-Y., Taylor B. C., Schousboe J. T., Donaldson M. G., Fink H. A., Cauley J. A., Hillier T. A., Browner W. S., Cummings S. R., A comparison of prediction models for fractures in older women: is more better? Archives of Internal Medicine 2009 169 22 2087 2094 2-s2.0-73149118490 10.1001/archinternmed.2009.404
75. Kanis J. A., Johnell O., Oden A., Johansson H., McCloskey E., FRAX ™ and the assessment of fracture probability in men and women from the UK. Osteoporosis International 2008 19 4 385 397 2-s2.0-43049175471 10.1007/s00198-007-0543-5
76. Schwartz A. V., Vittinghoff E., Bauer D. C., Hillier T. A., Strotmeyer E. S., Ensrud K. E., Donaldson M. G., Cauley J. A., Harris T. B., Koster A., Womack C. R., Palermo L., Black D. M., Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. The Journal of the American Medical Association 2011 305 21 2184 2192 2-s2.0-79957805100 10.1001/jama.2011.715
77. Naylor K., Eastell R., Bone turnover markers: use in osteoporosis. Nature Reviews Rheumatology 2012 8 7 379 389 2-s2.0-84863449316 10.1038/nrrheum.2012. 86
78. Chavassieux P., Seeman E., Delmas P. D., Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocrine Reviews 2007 28 2 151 164 2-s2.0-34249656211 10.1210/er.2006-0029 (Pubitemid 46984832)
79. Rice J. C., Cowin S. C., Bowman J. A., On the dependence of the elasticity and strength of cancellous bone on apparent density. Journal of Biomechanics 1988 21 2 155 168 2-s2.0-0023868463 (Pubitemid 18037418)
80. Bouxsein M. L., Bone quality: where do we go from here? Osteoporosis International 2003 14 supplement 5 S118 S127 2-s2.0-2342462537
81. Sanyal A., Gupta A., Bayraktar H. H., Kwon R. Y., Keaveny T. M., Shear strength behavior of human trabecular bone. Journal of Biomechanics 2012 45 15 2513 2519 2-s2.0-84866756668 10.1016/j.jbiomech.2012.07.023
82. Kanis J. A., Hans D., Cooper C., Baim S., Bilezikian J. P., Binkley N., Cauley J. A., Compston J. E., Dawson-Hughes B., El-Hajj Fuleihan G., Johansson H., Leslie W. D., Lewiecki E. M., Luckey M., Oden A., Papapoulos S. E., Poiana C., Rizzoli R., Wahl D. A., McCloskey E. V., Interpretation and use of FRAX in clinical practice. Osteoporosis International 2011 22 9 2395 2411 2-s2.0-80052313108 10.1007/s00198-011-1713-z
83. Genant H. K., Wu C. Y., van Kuijk C., Nevitt M. C., Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research 1993 8 9 1137 1148 2-s2.0-0027219544 (Pubitemid 23261108)
84. Black D. M., Arden N. K., Palermo L., Pearson J., Cummings S. R., Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Journal of Bone and Mineral Research 1999 14 5 821 828 2-s2.0-0032951747 10.1359/jbmr.1999.14.5.821 (Pubitemid 29210609)
85. Roux J. P., Wegrzyn J., Boutroy S., Relationship between Trabecular Bone Score (TBS), Bone Mass and Microarchitecture in Human vertebrae: an ex vivo study. Osteoporosis International 2012 23 supplement 2 S385 S386
86. Donnelly E., Methods for assessing bone quality: a review. Clinical Orthopaedics and Related Research 2011 469 8 2128 2138 2-s2.0-79960967249 10.1007/s11999-010-1702-0
87. Genant H. K., Engelke K., Prevrhal S., Advanced CT bone imaging in osteoporosis. Rheumatology 2008 47 4 iv9 iv16 2-s2.0-45749118746 10.1093/rheumatology/ken180 (Pubitemid 351865956)
88. Kazakia G. J., Majumdar S., New imaging technologies in the diagnosis of osteoporosis. Reviews in Endocrine and Metabolic Disorders 2006 7 1-2 67 74 2-s2.0-33846002765 10.1007/s11154-006-9004-2 (Pubitemid 46049521)
89. MacNeil J. A., Boyd S. K., Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Medical Engineering and Physics 2007 29 10 1096 1105 2-s2.0-34250018006 10.1016/j.medengphy.2006.11.002 (Pubitemid 350052626)
90. Carballido-Gamio J., Majumdar S., Clinical utility of microarchitecture measurements of trabecular bone. Current Osteoporosis Reports 2006 4 2 64 70 2-s2.0-33750332213 10.1007/s11914-006-0004-7 (Pubitemid 44623938)
91. Pothuaud L., Carceller P., Hans D., Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone 2008 42 4 775 787 2-s2.0-40849111375 10.1016/j.bone.2007.11.018
92. Rabier B., Héraud A., Grand-Lenoir C., Winzenrieth R., Hans D., A multicentre, retrospective case-control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): analysing the odds of vertebral fracture. Bone 2010 46 1 176 181 2-s2.0-72149124222 10.1016/j.bone.2009.06.032
93. Pothuaud L., Barthe N., Krieg M.-A., Mehsen N., Carceller P., Hans D., Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, Case-Control Study. Journal of Clinical Densitometry 2009 12 2 170 176 2-s2.0-67349199673 10.1016/j.jocd.2008.11.006
94. Hans D., Barthe N., Boutroy S., Pothuaud L., Winzenrieth R., Krieg M.-A., Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. Journal of Clinical Densitometry 2011 14 3 302 312 2-s2.0-79960902306 10.1016/j.jocd.2011.05.005
95. Dufour R., Heraud A., Lumbar spine micro-architecture in french women derived from DXA: TBS normative data. Journal of Clinical Densitometry 2009 12 3 377 378
96. Wegrzyn J., Roux J.-P., Arlot M. E., Boutroy S., Vilayphiou N., Guyen O., Delmas P. D., Chapurlat R., Bouxsein M. L., Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. Journal of Bone and Mineral Research 2010 25 11 2324 2331 2-s2.0-77958112630 10.1002/jbmr.164
97. Duan Y., Wang X.-F., Evans A., Seeman E., Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians. Bone 2005 36 6 987 998 2-s2.0-20444428007 10.1016/j.bone.2004.11.016 (Pubitemid 40797999)
98. van der Linden J. C., Homminga J., Verhaar J. A. N., Weinans H., Mechanical consequences of bone loss in cancellous bone. Journal of Bone and Mineral Research 2001 16 3 457 465 2-s2.0-0035101676 (Pubitemid 32173360)
99. Leslie W. D., Aubry-Rozier B., Lamy O., Hans D., TBS (trabecular bone score) and diabetes-related fracture risk. Journal of Clinical Endocrinology and Metabolism 2013 98 2 602 609 2-s2.0-84873640192 10.1210/jc.2012-3118
100. Jackuliak P., Payer J., Fracture Risk in Type 2 Diabetes and Trabecular Bone Score. Accepted for a Poster Presentation at the American Diabetes Association's 74th Scientific Sessions, San Francisco, Calif, USA, June 2014
101. Boutroy S., Hans D., Sornay-Rendu E., Vilayphiou N., Winzenrieth R., Chapurlat R., Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY Study. Osteoporosis International 2013 24 1 77 85 2-s2.0-84872291417 10.1007/s00198-012-2188-2
102. Lamy O., Metzger M., Krieg M.-A., Aubry-Rozier B., Stoll D., Hans D., OsteoLaus: prediction of osteoporotic fractures by clinical risk factors and DXA, IVA and TBS. Revue Medicale Suisse 2011 7 315 2130 2136 2-s2.0-84856630723
103. Vasic J., Gojkovic F., Petranova T., Elez J., Culafic V., Winzenrieth R., Hans D., Rashkov R., Dimic A., Spine micro-architecture estimation (TBS) discriminates major osteoporotic fracture from controls equally well than site matched BMD and independently: the eastern europe TBS Study. Osteoporosis International 2012 23 supplement 2 S337
104. Popp A. W., Meer S., Krieg M. A., Perrelet R., Hans D., Lippuner K., Bone mineral density (BMD) combined with micro-architecture parameters (TBS) significantly improves the indentification of women at high risk of fracture: the SEMOF cohort study. Osteoporosis International 2012 23 supplement 2 S327
105. Popp A. W., Guler S., Lamy O., Senn C., Buffat H., Perrelet R., Hans D., Lippuner K., Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study. Journal of Bone and Mineral Research 2013 28 3 449 454 2-s2.0-84873981329 10.1002/jbmr.1775
106. Kužma M., Kužmová Z., Zelinková Z., Killinger Z., Vaňuga P., Lazurová I., Tomková S., Payer J., Impact of the growth hormone replacement on bone status in growth hormone deficient adults. Growth Hormone and IGF Research 2014 24 1 22 28
107. Briot K., Paternotte S., Kolta S., Eastell R., Reid D. M., Felsenberg D., Glüer C. C., Roux C., Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS Study. Bone 2013 57 1 232 236 2-s2.0-84883382399 10.1016/j.bone.2013.07.040
108. National Osteoporosis Foundation, Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation 2010 Washington, DC, USA National Osteoporosis Foundation
109. Kanis J. A., Oden A., Johansson H., Borgström F., Ström O., McCloskey E., FRAX and its applications to clinical practice. Bone 2009 44 5 734 743 2-s2.0-63449088093 10.1016/j.bone.2009.01.373
110. Dawson-Hughes B., Mithal A., Bonjour J.-P., Boonen S., Burckhardt P., Fuleihan G. E.-H., Josse R. G., Lips P., Morales-Torres J., Yoshimura N., IOF position statement: vitamin D recommendations for older adults. Osteoporosis International 2010 21 7 1151 1154 2-s2.0-77957977517 10.1007/s00198-010-1285-3
111. Rizzoli R., Boonen S., Brandi M.-L., Bruyère O., Cooper C., Kanis J. A., Kaufman J.-M., Ringe J. D., Weryha G., Reginster J.-Y., Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion 2013 29 4 305 313 2-s2.0-84875201564 10.1185/03007995.2013.766162
112. Kanis J. A., McCloskey E. V., Johansson H., Cooper C., Rizzoli R., Reginster J.-Y., European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International 2013 24 1 23 57 2-s2.0-84872297244 10.1007/s00198-012-2074-y